Literature DB >> 17414586

Nitric oxide and malondialdehyde in human hypertension.

María Cristina Armas-Padilla1, María José Armas-Hernández, Beatriz Sosa-Canache, Rosalba Cammarata, Beatriz Pacheco, Jaime Guerrero, Atiff R Carvajal, Rafael Hernández-Hernández, Zafar H Israili, Manuel Valasco.   

Abstract

Nitric oxide (NO), a multifunctional effector molecule that plays a central role in the maintenance of vascular homeostasis, regulates vascular tone and inhibits platelet and leukocyte adhesion to endothelial cells. NO status is related to the endothelial function. Patients with hypertension have lower levels of NO, increased free radical production, higher oxidative stress, augmented platelet aggregation, and a change in the arachidonic acid cascade metabolism, all leading to the acceleration of the atherosclerotic process. The study subjects included a group of 21 normotensive healthy subjects (8 males and 13 females) with a mean age of 39.2 +/- 1.8 years and a body mass index of 27.9 kg/m, and another group of 42 patients (19 males and 23 females) with untreated essential hypertension with a mean age of 47.6 +/- 1.7 years and a body mass index of 28.3 kg/m. Serum levels and urinary excretion of NO determined as combined nitrate/nitrite (NOx) and serum malondialdehyde (MDA) concentrations were measured in the 2 groups of subjects. The serum levels and 24-hour urinary excretion of NOx were significantly higher and the renal clearance of NO was lower in the normotensive group than in the hypertensive patients, indicating decreased NO status in hypertension. There was a negative correlation between serum NO levels and mean arterial pressure, suggesting that a decrease in NO availability is related to increase in blood pressure. Serum concentrations of MDA were higher in the hypertensive patients as compared with the normotensive individuals, suggesting increased oxidative stress in hypertensive patients. These results are in agreement with previous studies showing decreased NO and increased oxidative stress in hypertension. In conclusion, patients with essential hypertension as compared with normotensive individuals have lower NO status, which may contribute to the endothelial dysfunction in hypertension. Increased serum malondialdehyde in hypertensives suggests an association between increased oxidative stress with higher blood pressure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414586     DOI: 10.1097/01.pap.0000249914.75895.48

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  21 in total

Review 1.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

2.  Serum Malondialdehyde Levels in Hypertensive Patients: A Non-invasive Marker of Oxidative Stress. A Systematic Review and Meta-analysis.

Authors:  Marco Zuin; Elenonora Capatti; Claudio Borghi; Giovanni Zuliani
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-03-28

Review 3.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

4.  Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure.

Authors:  Kelly A Hyndman; Erika I Boesen; Ahmed A Elmarakby; Michael W Brands; Paul Huang; Donald E Kohan; David M Pollock; Jennifer S Pollock
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

5.  Dynamin-2 is a novel NOS1β interacting protein and negative regulator in the collecting duct.

Authors:  Kelly A Hyndman; Alexandra M Arguello; Sofia K H Morsing; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-20       Impact factor: 3.619

6.  Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.

Authors:  S Yavuzer; H Yavuzer; M Cengiz; H Erman; M R Altıparmak; B Korkmazer; H Balci; G Simsek; A L Yaldıran; Y Karter; H Uzun
Journal:  J Hum Hypertens       Date:  2014-07-10       Impact factor: 3.012

7.  Biomarkers of lipid peroxidation related to hypertension in aging.

Authors:  Hakan Yavuzer; Serap Yavuzer; Mahir Cengiz; Hayriye Erman; Alper Doventas; Huriye Balci; Deniz Suna Erdincler; Hafize Uzun
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

8.  Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension.

Authors:  Hanna Pawluk; Robert Pawluk; Joanna Robaczewska; Kornelia Kędziora-Kornatowska; Józef Kędziora
Journal:  Redox Rep       Date:  2017-09-05       Impact factor: 4.412

9.  Nitric oxide and cardiovascular risk factors.

Authors:  Riccardo Raddino; Giorgio Caretta; Melissa Teli; Ivano Bonadei; Debora Robba; Gregoriana Zanini; Alberto Madureri; Savina Nodari; Livio Dei Cas
Journal:  Heart Int       Date:  2007-06-15

10.  Nigella sativa and Its Protective Role in Oxidative Stress and Hypertension.

Authors:  Xin-Fang Leong; Mohd Rais Mustafa; Kamsiah Jaarin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.